- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
FILING NO. 1 FOR THE MONTH OF SEPTEMBER, 2002
VISIBLE GENETICS INC.
-----------------------------------------
(Exact name of Registrant)
700 BAY STREET, SUITE 1000, TORONTO ON, CANADA M5G 1Z6
--------------------------------------------------------------
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F
Form 20-F X Form 40-F
--- ---
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
--- ---
- --------------------------------------------------------------------------------
VISIBLE GENETICS INC.
On or about September 9, 2002, we mailed to our shareholders a
Letter to Shareholders, Notice of Special Meeting of Shareholders, Management
Information Circular and Proxy Statement, each dated September 4, 2002, and
Proxy Card.
Exhibit 1. Letter to Shareholders, dated September 4, 2002
Exhibit 2. Notice of Special Meeting of Shareholders, dated September 4, 2002
Exhibit 3. Management Information Circular and Proxy Statement, dated
September 4, 2002
Exhibit 4. Form of Proxy
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
VISIBLE GENETICS INC.
Date: September 9, 2002 By: /s/ THOMAS J. CLARKE
-------------------------------
Name: Thomas J. Clarke
Title: Chief Financial Officer